Presentation is loading. Please wait.

Presentation is loading. Please wait.

EULAR Study Group on Registers and Observational Drug Studies (RODS)

Similar presentations


Presentation on theme: "EULAR Study Group on Registers and Observational Drug Studies (RODS)"— Presentation transcript:

1 EULAR Study Group on Registers and Observational Drug Studies (RODS)
What we do References- Courses - Publications Aim of the Study Group To create a platform for methodological, logistic, and scientific collaboration across European Rheumatology drug registers in order to maximise the potential use of the data collected within each register, to maximise the quality of the scientific outputs within and across registers, and to maximise the exchange of experiences across registries Organisation of the EULAR RODS meetings (1). Next meeting is planed on 30th November to 1st of December in Amsterdam Completion of a collaborative study on melanomas in relation to biological anti-rheumatic therapies, a joint effort across 11 European biologics registers (2). Completion of a collaborative study on lymphoma characteristics in relation to different RA therapies (3). EULAR Task Force on RA data harmonisation for registries (4). EULAR Task Force on GCA data harmonisation and core set of variable for registries (5) ters_observational_drug_studies_meetin g.cfm Mercer LK, Askling J, Raaschou P, et al. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers Annals of the Rheumatic Diseases 2017;76: Mercer LK, Regierer AC, Mariette X, et al. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project. Annals of the Rheumatic Diseases ;76: Radner H, Chatzidionysiou K, Nikiphorou E, et al EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Annals of the Rheumatic Diseases Published Online First: 04 January 2018 Who we are Rheumatologists, health professionals, statisticians, epidemiologist interested in clinical research using observational data Background Studies on rare exposures, uncommon outcomes, or personalised medicine require large samples that are increasingly difficult to obtain for any single investigator or registry EULAR has supported collaborations among national registers via several specific task forces to streamline collaborative research among registries Point of contact: Axel Finckh : Johan Askling:


Download ppt "EULAR Study Group on Registers and Observational Drug Studies (RODS)"

Similar presentations


Ads by Google